Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

27 Jan 2026 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Difluprednate Ophthalmic Emulsion, 0.05%. Enclosed its press release.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1797.20
Dr. Reddys Labs. 1352.55
Cipla 1373.70
Lupin 2010.00
Zydus Lifesciences 1238.25
View more..